Free preventive care under the ACA is under threat again – a ruling exempting PrEP from insurance coverage may extend nationwide and to other health services

Judge Reed O'Connor ruled in a case that coverage for HIV prevention medicine PrEP violated the religious freedom of the plaintiffs. It is unclear whether the order will extend nationwide.

Kristefer Stojanovski, Research Assistant Professor of Social, Behavioral and Population Sciences, Tulane University • conversation
Sept. 13, 2022 • ~8 min

Misinformation is a common thread between the COVID-19 and HIV/AIDS pandemics – with deadly consequences

The spread of misinformation in many pandemics, including the smallpox and 1918 influenza outbreaks, have undermined efforts to contain infections and prevent deaths.

Cristian Apetrei, Professor of Immunology, Infectious Diseases and Microbiology, University of Pittsburgh Health Sciences • conversation
Aug. 24, 2022 • ~9 min

HIV prevention pill PrEP is now free under most insurance plans – but the latest challenge to the Affordable Care Act puts this benefit at risk

World AIDS Day on Dec. 1 this year comes at a time when a key step to removing financial barriers to PrEP access in the U.S. faces legal challenges.

Kristefer Stojanovski, Research Assistant Professor of Social, Behavioral and Population Sciences, Tulane University • conversation
Dec. 1, 2021 • ~9 min

Deep learning helps predict new drug combinations to fight Covid-19

Neural network identifies synergistic drug blends for treating viruses like SARS-CoV-2.

Rachel Gordon | MIT CSAIL • mit
Sept. 24, 2021 • ~6 min

Fewer than one in 20 people living with HIV in England expected to be unaware of status by 2025

England is on track to have diagnosed 95% of people living with HIV by 2025, putting it in a strong position to eliminate HIV transmission by 2030, say

Cambridge University News • cambridge
Sept. 24, 2021 • ~6 min

Global herd immunity remains out of reach because of inequitable vaccine distribution – 99% of people in poor countries are unvaccinated

The high costs of the world's colossally unequal COVID-19 immunization rates.

Maria De Jesus, Associate Professor and Research Fellow at the Center on Health, Risk, and Society, American University School of International Service • conversation
June 22, 2021 • ~9 min

England on track to achieve elimination of HIV transmission by 2030 as model shows sharp decrease in HIV incidence

The annual number of new HIV infections among men who have sex with men in England is likely to have fallen dramatically, from 2,770 in 2013 to 854 in 2018,

Cambridge University News • cambridge
June 10, 2021 • ~4 min

HIV/AIDS vaccine: Why don't we have one after 37 years, when we have several for COVID-19 after a few months?

Scientists developed vaccines for COVID-19 in a matter of months. Why after 37 years do we still not have one for HIV/AIDS? On HIV Vaccine Awareness Day, it's an important question to ask.

Ronald C. Desrosiers, Professor of Pathology, Vice-chair for Research, University of Miami • conversation
May 17, 2021 • ~10 min

Model analyzes how viruses escape the immune system

Using this computational system, researchers can identify viral protein sequences that could make better vaccine targets.

Anne Trafton | MIT News Office • mit
Jan. 14, 2021 • ~8 min

How do pandemics end? History suggests diseases fade but are almost never truly gone

As ready as you are to be done with COVID-19, it's not going anywhere soon. A historian of disease describes how once a pathogen emerges, it's usually here to stay.

Nükhet Varlik, Associate Professor of History, University of South Carolina • conversation
Oct. 14, 2020 • ~9 min

/

4